Pasithea Therapeutics (KTTA) Competitor Comparison
We are evaluating the key criteria listed to compare Pasithea Therapeutics (KTTA) against its competitors in the Biotechnology industry.
Market Capitalization
350 / 368Gross Profits
0 / 278Total Revenue
251 / 300EBITDA
70 / 337Free Cashflow
92 / 352Quick Ratio
82 / 357Earnings per Share
343 / 359Dividend yield
0 / 6Total Cash
300 / 358Performance 3 years
321 / 368Performance 5 years
330 / 368Performance 10 years
297 / 368Linearity 3 years
265 / 368Linearity 5 years
279 / 368Linearity 10 years
259 / 368Total Rank
224 / 368Dividend Rank
234 / 368Valuation Rank
50 / 368Piotroski Rank
164 / 368Muliplier Rank
176 / 368Market Capitalization - KTTA ranking 350 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.